greeksoup/ stock research
Stock research / United States / Funds / BlackBarn Capital Partners LP

BlackBarn Capital Partners LP

CIK 2010204 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

BlackBarn Capital Partners LP reported 17 US-listed holdings worth $402.2 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Roivant Sciences Ltd. (17.6%), Privia Health Group, Inc. (10.1%) and Diversified Healthcare Trust (9.4%). Against the quarter before, it opened 5 positions, added to 3, trimmed 5 and sold out of 2.

Reported holdings$402.2M+21.0% on Q1 2026
Positions17+3 on Q1 2026
The largest ten81.4%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedAdded toHeldTrimmed
ROIV17.6%PRVA10.1%DHC9.4%NEE7.3%NIQ6.8%UNH6.7%NXPI6.3%VKTX5.8%MH5.8%AMRX5.6%VG4.8%AZUL3.8%OXY3.0%ABUS3.0%3 more4.0%

The 14 largest of its 17 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $230.1 million in 18 positions$230MQ3 24Q4 2024: $254.1 million in 15 positions$254MQ4 24Q1 2025: $292.8 million in 18 positions$293MQ1 25Q2 2025: $301.8 million in 20 positions$302MQ2 25Q3 2025: $306.4 million in 15 positions$306MQ3 25Q4 2025: $278.9 million in 11 positions$279MQ4 25Q1 2026: $332.4 million in 14 positions$332MQ1 26Q2 2026: $402.2 million in 17 positions$402MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +69.5% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100125150175Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +69.5%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 5Added 3Held 4Trimmed 5Sold out 2
Opened: 5Added: 3Held: 4Trimmed: 5Sold out: 2

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 5

  1. UnitedHealth Group Inc. UNH$27.0 million
  2. Venture Global Inc. VG$19.5 million
  3. Azul Sa-Spon ADR AZUL$15.1 million
  4. Occidental Petroleum Corp. OXY$12.1 million
  5. California Resources Corp. CRC$9.3 million

Added to 3

  1. NXP Semiconductors N.V. NXPI+30,000 shares · +50%
  2. Niq Global Intelligence PLC NIQ+829,101 shares · +40%
  3. McGraw Hill Inc. MH+361,508 shares · +17%

Trimmed 5

  1. Roivant Sciences Ltd. ROIV-285,117 shares · -12%
  2. Diversified Healthcare Trust DHC-737,413 shares · -15%
  3. Amneal Pharmaceuticals Inc. AMRX-350,000 shares · -21%
  4. Cogent Communications Holdings, Inc. CCOI-250,000 shares · -50%
  5. Viking Therapeutics Inc. VKTX-21,450 shares · -3%

Sold out of 2

  1. Veeco Instruments Inc. VECO$33.9 million last quarter
  2. Global Business Travel Group GBTG$11.2 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Roivant Sciences Ltd. ROIV2.0M$70.8 million17.60%-285.1K
Privia Health Group, Inc. PRVA1.6M$40.8 million10.14%no change
Diversified Healthcare Trust DHC4.1M$37.9 million9.42%-737.4K
NextEra Energy Inc. NEE335.0K$29.4 million7.31%no change
Niq Global Intelligence PLC NIQ2.9M$27.2 million6.75%+829.1K
UnitedHealth Group Inc. UNH65.0K$27.0 million6.72%new
NXP Semiconductors N.V. NXPI90.0K$25.3 million6.29%+30.0K
Viking Therapeutics Inc. VKTX600.0K$23.4 million5.82%-21.4K
McGraw Hill Inc. MH2.5M$23.2 million5.77%+361.5K
Amneal Pharmaceuticals Inc. AMRX1.3M$22.5 million5.60%-350.0K
Venture Global Inc. VG1.8M$19.5 million4.84%new
Azul Sa-Spon ADR AZUL1.7M$15.1 million3.76%new
Occidental Petroleum Corp. OXY250.0K$12.1 million3.02%new
Arbutus Biopharma Corp. ABUS2.5M$12.0 million2.98%no change
California Resources Corp. CRC175.0K$9.3 million2.30%new
Cogent Communications Holdings, Inc. CCOI250.0K$3.5 million0.86%-250.0K
Vivid Seats Inc. SEAT500.0K$3.3 million0.81%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 2 it sold out of are in the box above.

Options it reported

CompanyOptionShares under the optionsValue of those shares
SPDR S&P 500 SPYPuts800.0K$597.4 million
Oscar Health Inc. Class A OSCRPuts1.8M$49.9 million
UnitedHealth Group Inc. UNHCalls100.0K$41.6 million
Resmed Inc. RMDPuts200.0K$39.0 million
Venture Global Inc. VGCalls3.0M$33.4 million
Warby Parker Inc. WRBYPuts400.0K$12.1 million
Viking Therapeutics Inc. VKTXCalls250.0K$9.8 million

7 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.